Cargando…
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection
Autores principales: | Hariyanto, Timotius Ivan, Prasetya, Ignatius Bima, Kurniawan, Andree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538064/ https://www.ncbi.nlm.nih.gov/pubmed/33092998 http://dx.doi.org/10.1016/j.dld.2020.10.001 |
Ejemplares similares
-
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Authors’ response: Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19)
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2021)